Editor's note
According to " sound · responsibility " the data during informal discussion of committee member of the Chinese People's Political Consultative Conference of delegate of National People's Congress of medical bound whole nation, whole nation shows, in recent years, company of a few production or middleman use the means that the medicine of all raw material that controls a certain variety supplies, considerably value of drive up product, some rising in price extent is as high as severalfold, a few times, cause manufacturer of a few preparation to be able to be collected without raw material medicine, perhaps rise in price as a result of raw material medicine cost rises considerably. In survey breed, the price rises 70 times highest.
Raw material medicine rises in price pull used entire industry chain different link (factory price of finished product drug, win the bid retail price of valence, terminal) rise in price. The viewpoint thinks, some low are commonly used although medicine rises in price the day after all charge still did not exceed 3 yuan, but because remedial is the common chronic such as hypertension, compare anticarcinogen affect the range is wider. If cannot appropriate solves raw material medicine to rise in price problem, new the national medical service that establish is protected bureau the cure that roll out protects level of admittance of catalog of medicines and chemical reagents, state to be purchased centrally pilot etc depreciate the patient bonus that act brings, likelihood by raw material medicine " rise in price wet " place is quits.
Full text is read need 10 minutes about, if the article has any inspiration to you, the welcome clicks comment of language minor details.
The countrywide National People's Congress of pharmacy business represents the two conferences proposal of Xiong Wei politics, this week got the country is in charge of sectional answer. Reduce admittance of raw material medicine in the light of him it is condition, difficult to dissolve raw material medicine to supply and rise in price problem, answer of bureau of national medicine inspect says, medicines and chemical reagents superintends what the branch does not assume forestall of pair of raw material medicine to investigate duty, but can carry out medicines and chemical reagents to appear on the market in the round permissive holder (MAH) system. MAH system was regarded as to realize medicines and chemical reagents appear on the market license and manufacturing license photograph are detached, conduce to the raw material medicine that pushs our country entrusting production (CMO) mode.
China is big country of production of raw material drug and exit. Up to now, the drug of chemical raw material that branch of national medicine inspect approves has 1595 kinds, batch civil 8291. 2016, crop of medicine of raw material of chemistry of enterprise of countrywide dimensions above amounts to 3.289 million tons, relatively grew 6 times 2000 much. Satisfying domestic requirement effectively while, medicine of our country raw material is sold in great quantities toward the international market, it is international the industry that compares a dominant position certainly is had in competition.
However, namely such one is produced can the industry of the enough international market that prop up, partial breed appeared to supply however in short supply and rise in price considerably. 2017, association of Chinese medicine business management gets feedback from partial enterprise, because stop production of environmental protection reason is restricted,produce, sale of market forestall control is to cause medicine of partial raw material to supply in short supply the main reason that rises considerably with the price.
Raw material medicine rises in price, promoted medicine the direct cost of the product, bring about medical terminal product necessarily rise in price, the rise that also can affect the expenditure that use drug necessarily and see a doctor the settlement of expensive issue. The near future, according to Liaoning province medicines and chemical reagents purchases a net to release place to say centrally, should save 81 kinds of drug that cannot supply normally, as a result of the supply of raw material medicine shortage is reached those who rise in price have 42, exceed an in part. For instance chlorpheniramine rises 58 times, phenol rises 99 times. Rise to having no end, still see the trend that is less than fall after a rise at present. So, such rising in price reasonable? Rise in price have is without the likelihood control in certain extent? A few bigger unreasonable rise extent whether get keep within limits reconciles definitely?
Answer raw material medicine to rise in price considerably, urgent affairs is fall unreasonable price increment space, price management can adopt style of campaign of legal measure and rather than to execute the law only. Serve as the plan of the effect a permanent cure, we need to reform drug price to run system in the round, the price of raw material drug with work up reasonable science forms a mechanism.
◆ ◆ ◆
"One knife is cut " medicine of raw material of aggravation of the action that treat haze is supplied
From the reasonable production of raw material medicine cost looks, current cost promotion is very fast, its reason includes but not be confined to: It is environmental protection asks to rise substantially. Because the government asks duty of the system build, concerned branch is strict according to law standard of requirement of regulation, policy, technology handles affairs, catch very closely, allow to hit edge ball no longer, promoted the production of raw material medicine cost substantially thereby. This is the main reason that cost rises; The products of 2 raw material chemical industry that are raw material medicine reach intermediate put oneself in another's position raise price; 3 it is specific power consumption of raw material drug tall, ascendant impact of price of the sources of energy is big; The 4 promotion that are artificial charge; 5 it is new round the devoted need booth that GMP transforms enters cost; 6 it is extensive of production of raw material drug, reclaim little, discharge directly much, reclaim to reduce pollution to increase now, processing cost rises necessarily; 7 it is safe production got attention, also drove those who produce cost to rise.
So, of raw material medicine rise in price moderately, digested these reasonable cost, of the improvement of environment of the promotion that is helpful for quality of medicines and chemical reagents, zoology and quality of enterprise rise.
Nevertheless, the overcorrect problem that appears in the process that also should avoid partial area to be polluted in the environment such as processing mist haze. The data that brings chamber of commerce of medicine of in relief city to offer shows, what branch of local environmental protection executes to drug production company is simple and crude, " one knife is cut " measure, namely company of production of drug of all raw material is same stop production. Chamber of commerce has company of drug of 4 raw material, the product of raw material drug of onefold breed takes home market 70% above, take an international market 80% above, after stop production, cause raw material medicine to break for, downstream production of drug of hundreds of tablet, injection, capsule is about to be forced stop production shutdown.
Look from the normal market supply and demand of raw material medicine, demand exceeds supply in recent years, its reason includes but not be confined to: It is some raw material medicine production is approved article is less, and the manufacturer home of need is more; 2 it is environmental protection has not been connected or GMP has not been connected, stop production of a few companies changes the line of production; 3 it is companies of some raw material drug because of town planning by in a limited time remove; 4 it is cost rises to maintain simple reproduction hard, a few enterprises hold a group in the arms to warm oneself, increased the cooperation between the enterprise, rose to take the possibility that acts jointly. In the meantime, also do not eliminate person of company of drug of a few raw material to be " bogus is in short supply " .
Change according to these, because in-house cost is mixed,the put together collaboration of two respects element uses exterior market, of raw material medicine rising in price is normal it is inevitable even. This proved the price is the crucial segment that the product enters the market again. Only the market makes public competition, government to run the price that form lawfully, just be scientific and reasonable, have vitality durative.
◆ ◆ ◆
Raw material medicine rises in price considerably: Antitrust investigation must be started
However, problem not so simple. A few medicines and chemical reagents produce an enterprise to think, before price of raw material drug is lower, promote now a certain number of percent even a certain number of times, it is to be able to understand, can accept. But, like money new network announces in that way, rise ten times, a few times, that is not normal market competitive reason can explain, have factitious operation among them for certain, perhaps have a special case factor among them?
There is the voice of a kind of suspicion in social public opinion, think raw material medicine rises in price considerably, be suspected of company of drug of a few raw material be below the circumstance that manufacturing cost rises normally, use the monopoly position of supply demand relations, produce a business jointly with medicine of other raw material or run a company, use total classics (bag) annul, buy outright have exclusive selling rights wait for means, borrow machine undertake unreasonable rise in price. This year the whole nation during two meetings, also medical bound represents commissarial appeal, enterprise of individual raw material is transformed with environmental protection for fool case of raise up the price intentionally, or enterprise of raw material of much home of combination of individual medicine company forms alliance, price of raw material of drive up of hold the market.
From the point of the individual case that raw material medicine rises in price now, somebody suspects a few enterprise is suspected of disobeying " antitrust law " , hold the market, operate the price, be not an empty hole invites the wind-weakness lends wings to rumors, possibility is being had at least on logic. But factual truth and conclusion, can arise to execute the law in antitrust only of the orgnaization after be being investigated lawfully.
Because forestall has been formed, inform against raw material medicine unreasonable rise in price, till break,offer with respect to the supply that can affect pharmaceutical factory. So, proposal antitrust executes the law the orgnaization accepts a secret to inform against. It is the person that inform against to keep secret. All processing all are made after the examination. Solid to checking break the law rise in price, ought to carry case punishment on the head.
Accordingly, earnest hope antitrust executes the law special investigation and antitrust survey the cost price that the orgnaization starts businesses of pair of raw material drug that rise in price considerably as early as possible, investigate lawfully fool case of raise up the price and forestall to wait of all kinds break the law violate compasses act, cannot allow to be eached does what he thinks is right by each, its mention each word, mutual even follow the lead of, grow in intensity. This meeting destroys market order, tear off human relations in society, damage governmental image, the disorder of aggravate medicine domain.
◆ ◆ ◆
Simplify examine and approve, break raw material medicine to supply rig
In the meantime, to be in short supply and rising in price extent passes old raw material drug, the country should establish quick response mechanism, enlightened fast summary approves a passageway, simplify examine and approve a program, the raw material drug that adds a condition to have produces batch of article, supply in order to increase, smash up a monopoly. The crisis that also avoids shortage and price to rise considerably spreads to the category of clinical medicines and chemical reagents such as preparation.
Actually, the raw material medicine that erupts quickly now rises in price considerably, clue has been shown a few years first afore, raw material medicine rises in price severalfold thing, had happened for many times before this. But as a result of forestall, assume directly rise in price sequential medicines and chemical reagents produces a business, did not phonate large-scaly. This ten times of a few times rise in price, went to drug production company really hard susceptive degree, so, contradiction erupts eventually. From this thing, can see, our country approves the examination of article to manage to raw material medicine, what did not reflect the State Council to decide is wide the principle that advances severe canal.
Batch of article wide receive severe valve, the production that should increase medicine of congener raw material appropriately namely is approved civil, make sure in the production of medicine of congener raw material the domain forms measurable competition. Only wide into, ability causes competition, satisfy requirement, smash up a monopoly; Have severe canal only, ability standard competes, assure safety, prevent a disorder. Wide enter the foundation that laid severe pipe, and severe canal was achieved wide the aim that take, wide enter and severe canal solved domain of raw material medicine to put random, valve jointly dead problem.
(the author saves medicines and chemical reagents of food of city of medical guild former chairman, Hangzhou to superintend bureau former director for Zhejiang, the article does not nod a viewpoint on behalf of health)
Article head hair nods Caixin-life at money new health;
Contribute means: Healthpoint@caixin.com;
Liang Jialin | Editor-in-charge
Popular read:
Business affairs cooperates:
Beijing Fiona 18612891987
Shanghai Kevin 18621849119
